Excited to share our latest work: “liquid biopsy epigenomic profiling for cancer subtyping”, JUST IN Nature Medicine nature.com/articles/s4159…

#UMCCR's fredhollande recently presented at the 2023 PanKind Scientific Meeting which brought together Aus researchers to discuss issues related to #PancreaticCancer including early detection, effective health care policy, and targeted therapy options. mdhs.unimelb.edu.au/centre-for-can…

Delighted to see Pathology Journal Editor-in-Chief @ProfRScolyerMIA named NSW's 2024 Australian of the Year, with colleague Professor Georgina Long AO (Bluesky @gvlongphdmd). The award recognises their extraordinary work in #melanomaresearch, and drive to continue innovating in #cancer research and treatment.

Or more likely to line some overpaid "fundraiser's" pocket. Try to donate only to reputable charities who minimise their overheads!

Thank you, Diane M. Simeone, MD, for joining our Meeting and sharing your knowledge on current advances in pancreatic cancer.

Heros!!!

Our latest paper @NAROpen looks at how ribonucleoside analog drugs can impact the genome and how this varies based on metabolic wiring in cell lines. Uridine–cytidine kinase 2 potentiates the mutagenic influence of the antiviral β-d-N4-hydroxycytidine doi.org/10.1093/nar/gk…

😯 François Jacob (co-discoverer of gene regulation) asked by Lucy Shapiro (Stanford): "It's always been hypothesis-driven research [..] but a new way is looking at vast amounts of data and not asking a question, just seeing if it give you a pattern." Jacob: "It’s very boring.."

Groundbreaking research in Boston could change prostate cancer treatment wcvb.com/article/boston…

Sounds all too familiar!

Inaugural Austin Health Advanced Liver Disease Symposium locked in for February 2024. A great educational opportunity for Victorian physicians, trainees, nursing and allied health staff with an interest in critical care hepatology! trybooking.com/events/landing…

Is this the first study of #cfDNA in extracorporeal circulation? Daniel Cox TranslationalGenomic

Breaking news: #Albo mounts a challenge for leadership of the Liberal party!

Circulating tumor DNA for monitoring colorectal cancer: A prospective observational study to assess the presence of methylated SEPT9 and VIM promoter genes and its role as a biomarker in colorectal cancer management dlvr.it/SzVKK2

Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients dlvr.it/SzVKK3

The oration seminar today Peter Mac Research by my PhD supervisor, Prof Rob Ramsay, was incredible and may be the best seminar I have ever attended. He summarised his 40 year inspirational and medical research changing career so beautifully. Enjoy your retirement Rob, well deserved xo

I was wondering how long before this happen?

What causes a false➕liquid biopsy? This is probably the first report of a false➕methylation signal from a very high hepatitis C viremia🦠. 💡As methylation gets used for MRD & early detection, consider non-cancer diseases. OncoAlert International Society of Liquid Biopsy karger.com/cro/article/16…